Mark E. Lawrence, D.O.

Clinical Cardiology, Interventional Cardiology

Assistant Professor of Internal Medicine

Interventional Fellowship, Brown University, Providence, RI, 1995-1996
Cardiology Fellowship, Texas A&M College of Medicine/Scott & White, Temple, TX, 1992-1995
Internal Medicine Residency, Texas A&M College of Medicine/Scott & White, Temple, TX, 1989-1992

July 1, 1996

Fitzsimmons PJ, Forough R, Lawrence ME. Gantt DS, Rajab MH, Kim H, Weylie B, Spiekerman AM, Dehmer GJ. Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease. Atherosclerosis 2007; 194:151-58.
Lawrence ME, Mixon TA, Cross DA, Gantt DS, Dehmer GJ.
Assessment of anticoagulation using activated clotting times in patients receiving intravenous enoxaparin during percutaneous coronary intervention.
Catheterization and Cardiovascular Interventions 2004; 61[1]:52-55.
Mixon TA, Cross DS, Lawrence ME, Gantt DS, Dehmer GJ.
Temporary coronary guidewire pacing during percutaneous coronary intervention.
Catheterization and Cardiovascular Interventions 2004; 61[4]:494-500.
Palmer BL, Gantt DS, Lawrence ME, Rajab MH, Dehmer GJ.
Effectiveness and safety of manual hemostasis facilitated by the SyvekPatch with one hour of bedrest after coronary angiography using six-French catheters.
American Journal of Cardiology 2004; 93[1]:96-97.
Read more publications.

Interventional cardiology

Water skiing, weight lifting, hunting, fishing

Scott & White • 2401 S. 31^st St. • Temple, TX 76508

• 254-724-2111 • 800-792-3710 • 254-724-3038 (TTY)